Note 5 - Revenue |
6 Months Ended |
|---|---|
Jun. 30, 2026 | |
| Statement Line Items [Line Items] | |
| Disclosure of revenue [text block] |
Note 5. Revenue
During the three and six months ended June 30, 2026, no revenue has been recognized.
In June 2025, the Gates Foundation awarded the Company a grant of $0.1 million to help the world eradicate polio (poliomyelitis) by exploring design options for a new and unique vaccine. During the three and six months ended June 30, 2025, the Company recognized a nominal amount of grant revenue related to the Gates Foundation Grant. |